DeutschNewstral
Ken Cacciatore
- MNetflix, Workday, Costco, Caterpillar and more: These stocks are Cowen's favorites for 20234 min readmarketwatch.com
- IThis analyst raised his price target on Impel NeuroPharma by more than 50%invezz.com
- MAllergan beats second-quarter expectations, boosts full-year guidancemarketwatch.com
- HTeva Shares Up on Mylan-Pfizer Mergerhamodia.com
- MWall Street is not exactly impressed with the Pfizer-Mylan dealmarketwatch.com
MÄRKTE-US-Pharmakonzern Mylan winkt größter Tagesgewinn seit 2000Reuters- MÄRKTE-US-Zulassung für "Viagra für Frauen" treibt Amag-Aktien anReuters
- M‘This will likely end badly’: Analysts react to Mylan’s revenue miss and earnings callmarketwatch.com
- MAllergan stock slips despite revenue beat, a sign of investors’ worries over company’s futuremarketwatch.com
- MDeclining sales of blockbuster drug drag Teva revenue lowermarketwatch.com
Business in Brief: Leumi Quarterly Profit Boosted by Insurance Reimbursement for U.S. PenaltyHaaretz
Analysts ask if Mylan can make case for Perrigo purchase with its shareholdersbizjournals.com
Allergan may turn sights to Amgen or AbbVieThe Salt Lake Tribune
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com
Mylan created Dutch-style poison pill to protect itselfpost-gazette.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.